The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rh Immunoglobulin Market Research Report 2025
Synopsis
Rh immune globulin is a prescription drug used to prevent the mother of Rh-negative blood from producing anti-D antibodies in response to Rh-positive blood. The function of anti-D immune globulin is to destroy the Rh-(D) antigen entering the maternal blood and inhibit the production of anti-Rh-(D) antibodies in the maternal blood, thereby preventing Rh immune response.
The global Rh Immunoglobulin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rh Immunoglobulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rh Immunoglobulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rh Immunoglobulin include CSL Behring, Johnson & Johnson, Bayer, WELLONA PHARMA and Kamada Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rh Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rh Immunoglobulin.
Report Scope
The Rh Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rh Immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rh Immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Behring
Johnson & Johnson
Bayer
WELLONA PHARMA
Kamada Pharmaceuticals
Segment by Type
RhoGAM Immunoglobulin
WinRho®SDF
HyperRho®S/D
Segment by Application
Rh Negative Female Giving Birth
Miscarriage In Rh-Negative Women
Rh-Negative Women Receive Positive Blood Transfusion
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rh Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rh Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Rh immune globulin is a prescription drug used to prevent the mother of Rh-negative blood from producing anti-D antibodies in response to Rh-positive blood. The function of anti-D immune globulin is to destroy the Rh-(D) antigen entering the maternal blood and inhibit the production of anti-Rh-(D) antibodies in the maternal blood, thereby preventing Rh immune response.
The global Rh Immunoglobulin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rh Immunoglobulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rh Immunoglobulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rh Immunoglobulin include CSL Behring, Johnson & Johnson, Bayer, WELLONA PHARMA and Kamada Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rh Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rh Immunoglobulin.
Report Scope
The Rh Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rh Immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rh Immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Behring
Johnson & Johnson
Bayer
WELLONA PHARMA
Kamada Pharmaceuticals
Segment by Type
RhoGAM Immunoglobulin
WinRho®SDF
HyperRho®S/D
Segment by Application
Rh Negative Female Giving Birth
Miscarriage In Rh-Negative Women
Rh-Negative Women Receive Positive Blood Transfusion
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rh Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rh Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Rh Immunoglobulin Market Overview
1.1 Product Overview and Scope of Rh Immunoglobulin
1.2 Rh Immunoglobulin Segment by Type
1.2.1 Global Rh Immunoglobulin Market Value Comparison by Type (2024-2030)
1.2.2 RhoGAM Immunoglobulin
1.2.3 WinRho®SDF
1.2.4 HyperRho®S/D
1.3 Rh Immunoglobulin Segment by Application
1.3.1 Global Rh Immunoglobulin Market Value by Application: (2024-2030)
1.3.2 Rh Negative Female Giving Birth
1.3.3 Miscarriage In Rh-Negative Women
1.3.4 Rh-Negative Women Receive Positive Blood Transfusion
1.3.5 Other
1.4 Global Rh Immunoglobulin Market Size Estimates and Forecasts
1.4.1 Global Rh Immunoglobulin Revenue 2019-2030
1.4.2 Global Rh Immunoglobulin Sales 2019-2030
1.4.3 Global Rh Immunoglobulin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Rh Immunoglobulin Market Competition by Manufacturers
2.1 Global Rh Immunoglobulin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Rh Immunoglobulin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Rh Immunoglobulin Average Price by Manufacturers (2019-2024)
2.4 Global Rh Immunoglobulin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rh Immunoglobulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rh Immunoglobulin, Product Type & Application
2.7 Rh Immunoglobulin Market Competitive Situation and Trends
2.7.1 Rh Immunoglobulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rh Immunoglobulin Players Market Share by Revenue
2.7.3 Global Rh Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rh Immunoglobulin Retrospective Market Scenario by Region
3.1 Global Rh Immunoglobulin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Rh Immunoglobulin Global Rh Immunoglobulin Sales by Region: 2019-2030
3.2.1 Global Rh Immunoglobulin Sales by Region: 2019-2024
3.2.2 Global Rh Immunoglobulin Sales by Region: 2025-2030
3.3 Global Rh Immunoglobulin Global Rh Immunoglobulin Revenue by Region: 2019-2030
3.3.1 Global Rh Immunoglobulin Revenue by Region: 2019-2024
3.3.2 Global Rh Immunoglobulin Revenue by Region: 2025-2030
3.4 North America Rh Immunoglobulin Market Facts & Figures by Country
3.4.1 North America Rh Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Rh Immunoglobulin Sales by Country (2019-2030)
3.4.3 North America Rh Immunoglobulin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rh Immunoglobulin Market Facts & Figures by Country
3.5.1 Europe Rh Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Rh Immunoglobulin Sales by Country (2019-2030)
3.5.3 Europe Rh Immunoglobulin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rh Immunoglobulin Market Facts & Figures by Country
3.6.1 Asia Pacific Rh Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Rh Immunoglobulin Sales by Country (2019-2030)
3.6.3 Asia Pacific Rh Immunoglobulin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rh Immunoglobulin Market Facts & Figures by Country
3.7.1 Latin America Rh Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Rh Immunoglobulin Sales by Country (2019-2030)
3.7.3 Latin America Rh Immunoglobulin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Rh Immunoglobulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Rh Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Rh Immunoglobulin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Rh Immunoglobulin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rh Immunoglobulin Sales by Type (2019-2030)
4.1.1 Global Rh Immunoglobulin Sales by Type (2019-2024)
4.1.2 Global Rh Immunoglobulin Sales by Type (2025-2030)
4.1.3 Global Rh Immunoglobulin Sales Market Share by Type (2019-2030)
4.2 Global Rh Immunoglobulin Revenue by Type (2019-2030)
4.2.1 Global Rh Immunoglobulin Revenue by Type (2019-2024)
4.2.2 Global Rh Immunoglobulin Revenue by Type (2025-2030)
4.2.3 Global Rh Immunoglobulin Revenue Market Share by Type (2019-2030)
4.3 Global Rh Immunoglobulin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Rh Immunoglobulin Sales by Application (2019-2030)
5.1.1 Global Rh Immunoglobulin Sales by Application (2019-2024)
5.1.2 Global Rh Immunoglobulin Sales by Application (2025-2030)
5.1.3 Global Rh Immunoglobulin Sales Market Share by Application (2019-2030)
5.2 Global Rh Immunoglobulin Revenue by Application (2019-2030)
5.2.1 Global Rh Immunoglobulin Revenue by Application (2019-2024)
5.2.2 Global Rh Immunoglobulin Revenue by Application (2025-2030)
5.2.3 Global Rh Immunoglobulin Revenue Market Share by Application (2019-2030)
5.3 Global Rh Immunoglobulin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Rh Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Behring Rh Immunoglobulin Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Rh Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Rh Immunoglobulin Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Rh Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Rh Immunoglobulin Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 WELLONA PHARMA
6.4.1 WELLONA PHARMA Corporation Information
6.4.2 WELLONA PHARMA Description and Business Overview
6.4.3 WELLONA PHARMA Rh Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 WELLONA PHARMA Rh Immunoglobulin Product Portfolio
6.4.5 WELLONA PHARMA Recent Developments/Updates
6.5 Kamada Pharmaceuticals
6.5.1 Kamada Pharmaceuticals Corporation Information
6.5.2 Kamada Pharmaceuticals Description and Business Overview
6.5.3 Kamada Pharmaceuticals Rh Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kamada Pharmaceuticals Rh Immunoglobulin Product Portfolio
6.5.5 Kamada Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rh Immunoglobulin Industry Chain Analysis
7.2 Rh Immunoglobulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rh Immunoglobulin Production Mode & Process
7.4 Rh Immunoglobulin Sales and Marketing
7.4.1 Rh Immunoglobulin Sales Channels
7.4.2 Rh Immunoglobulin Distributors
7.5 Rh Immunoglobulin Customers
8 Rh Immunoglobulin Market Dynamics
8.1 Rh Immunoglobulin Industry Trends
8.2 Rh Immunoglobulin Market Drivers
8.3 Rh Immunoglobulin Market Challenges
8.4 Rh Immunoglobulin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Rh Immunoglobulin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Rh Immunoglobulin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Rh Immunoglobulin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Rh Immunoglobulin Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Rh Immunoglobulin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Rh Immunoglobulin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Rh Immunoglobulin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Rh Immunoglobulin Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Rh Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Rh Immunoglobulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rh Immunoglobulin, Product Type & Application
Table 12. Global Key Manufacturers of Rh Immunoglobulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rh Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rh Immunoglobulin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rh Immunoglobulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Rh Immunoglobulin Sales by Region (2019-2024) & (K Units)
Table 18. Global Rh Immunoglobulin Sales Market Share by Region (2019-2024)
Table 19. Global Rh Immunoglobulin Sales by Region (2025-2030) & (K Units)
Table 20. Global Rh Immunoglobulin Sales Market Share by Region (2025-2030)
Table 21. Global Rh Immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Rh Immunoglobulin Revenue Market Share by Region (2019-2024)
Table 23. Global Rh Immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Rh Immunoglobulin Revenue Market Share by Region (2025-2030)
Table 25. North America Rh Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Rh Immunoglobulin Sales by Country (2019-2024) & (K Units)
Table 27. North America Rh Immunoglobulin Sales by Country (2025-2030) & (K Units)
Table 28. North America Rh Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Rh Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Rh Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Rh Immunoglobulin Sales by Country (2019-2024) & (K Units)
Table 32. Europe Rh Immunoglobulin Sales by Country (2025-2030) & (K Units)
Table 33. Europe Rh Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Rh Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Rh Immunoglobulin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Rh Immunoglobulin Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Rh Immunoglobulin Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Rh Immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Rh Immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Rh Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Rh Immunoglobulin Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Rh Immunoglobulin Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Rh Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Rh Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Rh Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Rh Immunoglobulin Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Rh Immunoglobulin Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Rh Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Rh Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Rh Immunoglobulin Sales (K Units) by Type (2019-2024)
Table 51. Global Rh Immunoglobulin Sales (K Units) by Type (2025-2030)
Table 52. Global Rh Immunoglobulin Sales Market Share by Type (2019-2024)
Table 53. Global Rh Immunoglobulin Sales Market Share by Type (2025-2030)
Table 54. Global Rh Immunoglobulin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Rh Immunoglobulin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Rh Immunoglobulin Revenue Market Share by Type (2019-2024)
Table 57. Global Rh Immunoglobulin Revenue Market Share by Type (2025-2030)
Table 58. Global Rh Immunoglobulin Price (US$/Unit) by Type (2019-2024)
Table 59. Global Rh Immunoglobulin Price (US$/Unit) by Type (2025-2030)
Table 60. Global Rh Immunoglobulin Sales (K Units) by Application (2019-2024)
Table 61. Global Rh Immunoglobulin Sales (K Units) by Application (2025-2030)
Table 62. Global Rh Immunoglobulin Sales Market Share by Application (2019-2024)
Table 63. Global Rh Immunoglobulin Sales Market Share by Application (2025-2030)
Table 64. Global Rh Immunoglobulin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Rh Immunoglobulin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Rh Immunoglobulin Revenue Market Share by Application (2019-2024)
Table 67. Global Rh Immunoglobulin Revenue Market Share by Application (2025-2030)
Table 68. Global Rh Immunoglobulin Price (US$/Unit) by Application (2019-2024)
Table 69. Global Rh Immunoglobulin Price (US$/Unit) by Application (2025-2030)
Table 70. CSL Behring Corporation Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Rh Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. CSL Behring Rh Immunoglobulin Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Rh Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Johnson & Johnson Rh Immunoglobulin Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Rh Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bayer Rh Immunoglobulin Product
Table 84. Bayer Recent Developments/Updates
Table 85. WELLONA PHARMA Corporation Information
Table 86. WELLONA PHARMA Description and Business Overview
Table 87. WELLONA PHARMA Rh Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. WELLONA PHARMA Rh Immunoglobulin Product
Table 89. WELLONA PHARMA Recent Developments/Updates
Table 90. Kamada Pharmaceuticals Corporation Information
Table 91. Kamada Pharmaceuticals Description and Business Overview
Table 92. Kamada Pharmaceuticals Rh Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Kamada Pharmaceuticals Rh Immunoglobulin Product
Table 94. Kamada Pharmaceuticals Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Rh Immunoglobulin Distributors List
Table 98. Rh Immunoglobulin Customers List
Table 99. Rh Immunoglobulin Market Trends
Table 100. Rh Immunoglobulin Market Drivers
Table 101. Rh Immunoglobulin Market Challenges
Table 102. Rh Immunoglobulin Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rh Immunoglobulin
Figure 2. Global Rh Immunoglobulin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Rh Immunoglobulin Market Share by Type in 2023 & 2030
Figure 4. RhoGAM Immunoglobulin Product Picture
Figure 5. WinRho®SDF Product Picture
Figure 6. HyperRho®S/D Product Picture
Figure 7. Global Rh Immunoglobulin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Rh Immunoglobulin Market Share by Application in 2023 & 2030
Figure 9. Rh Negative Female Giving Birth
Figure 10. Miscarriage In Rh-Negative Women
Figure 11. Rh-Negative Women Receive Positive Blood Transfusion
Figure 12. Other
Figure 13. Global Rh Immunoglobulin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Rh Immunoglobulin Market Size (2019-2030) & (US$ Million)
Figure 15. Global Rh Immunoglobulin Sales (2019-2030) & (K Units)
Figure 16. Global Rh Immunoglobulin Average Price (US$/Unit) & (2019-2030)
Figure 17. Rh Immunoglobulin Report Years Considered
Figure 18. Rh Immunoglobulin Sales Share by Manufacturers in 2023
Figure 19. Global Rh Immunoglobulin Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Rh Immunoglobulin Players: Market Share by Revenue in 2023
Figure 21. Rh Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Rh Immunoglobulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Rh Immunoglobulin Sales Market Share by Country (2019-2030)
Figure 24. North America Rh Immunoglobulin Revenue Market Share by Country (2019-2030)
Figure 25. United States Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Rh Immunoglobulin Sales Market Share by Country (2019-2030)
Figure 28. Europe Rh Immunoglobulin Revenue Market Share by Country (2019-2030)
Figure 29. Germany Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Rh Immunoglobulin Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Rh Immunoglobulin Revenue Market Share by Region (2019-2030)
Figure 36. China Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Rh Immunoglobulin Sales Market Share by Country (2019-2030)
Figure 46. Latin America Rh Immunoglobulin Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Colombia Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Rh Immunoglobulin Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Rh Immunoglobulin Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Rh Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Rh Immunoglobulin by Type (2019-2030)
Figure 57. Global Revenue Market Share of Rh Immunoglobulin by Type (2019-2030)
Figure 58. Global Rh Immunoglobulin Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Rh Immunoglobulin by Application (2019-2030)
Figure 60. Global Revenue Market Share of Rh Immunoglobulin by Application (2019-2030)
Figure 61. Global Rh Immunoglobulin Price (US$/Unit) by Application (2019-2030)
Figure 62. Rh Immunoglobulin Value Chain
Figure 63. Rh Immunoglobulin Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
